While our attention is primarily directed toward understanding the reprogramming of TAM lipid metabolism via SREBP in HCC, it is crucial to recognize the significance of its upstream pathways, such as the mTOR kinase. This evidence concerns the gene MTOR and hepatocellular carcinoma.